Literature DB >> 3922807

Hormonal parameters of men with varicoceles before and after varicocelectomy.

R W Hudson, R A Perez-Marrero, V A Crawford, D E McKay.   

Abstract

The gonadotropin responses to a 4-hour infusion of gonadotropin-releasing hormone (GnRH) and seminal plasma dihydrotestosterone (DHT) and testosterone levels were assessed before and 6 to 12 months after varicocelectomy in 22 men with varicoceles. Twelve men were severely oligozoospermic (sperm densities less than 10 X 10(6)/ml), whereas 10 men had sperm densities between 11 and 30 X 10(6)/ml. Each man had excessive gonadotropin responses to GnRH and lower than normal seminal plasma DHT levels preoperatively. Eight of the 12 severely oligozoospermic men and 6 of the other 10 men had postoperative improvements in sperm density. These men (responders) had normalization of gonadotropin response and seminal plasma DHT levels. The nonresponders had identical hormonal parameters before and after surgery. These results indicate that the pantesticular defect in hormonal synthesis and spermatogenesis, seen in some men with varicoceles, can be reversible.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922807

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Varicocele in adolescence: where are we now?

Authors:  Laura S Merriman; Andrew J Kirsch
Journal:  Curr Urol Rep       Date:  2012-08       Impact factor: 3.092

2.  Yq microdeletions--azoospermia factor candidate genes and spermatogenic arrest.

Authors:  Rima Dada; N P Gupta; K Kucheria
Journal:  J Biomol Tech       Date:  2004-09

Review 3.  The adolescent varicocele: treatment and outcome.

Authors:  Evan J Kass
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 2.862

Review 4.  Novel insights into the pathophysiology of varicocele and its association with reactive oxygen species and sperm DNA fragmentation.

Authors:  Chak-Lam Cho; Sandro C Esteves; Ashok Agarwal
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.